Alcon Inc.
(NYSE:ACL)|
82.03 -1.99 (-2.37%) Dec 04 - Close |
|
|
|
After-Hours 82.41 +0.38 (0.46%) Thu, 4 Dec 2008 7:40 PM
- Compare ACL with:
- View: Line | Candlestick
Company Profile
Alcon Inc.
Bosch 69
Hunenberg, 6331
Switzerland - Map
Phone: 41 41 7858888
Fax: 41 41 7858887
Website: www.alconinc.com
CEO: Cary R. Rayment
Employees: 14,500
Sector: Healthcare
Industry Group: Health Services
Industry: Medical Instruments & Supplies
Dev/manu/mrkts eye care products
A global medical specialty company, that develops, manufactures and markets pharmaceuticals, surgical equipment & devices and consumer eye care products to treat primarily diseases & disorders of the eye.
Recent news for ACL
-
Europe approves Alcon's Azarga glaucoma treatment
Reuters - Yesterday at 4:47 ET
-
Alcon cleared in Europe for drop for intraocular pressure
MarketWatch - Yesterday at 4:19 ET
-
Business Wire - Dec 02 at 6:41 ET
-
Analysts' Upgrades, Downgrades: Microsoft
TheStreet.com - Dec 01 at 9:11 ET
-
Briefing.com - Dec 01 at 6:49 ET
-
[$$] Short Medical-Device Plays After Obama's Win
RealMoney by TheStreet.com - Nov 19 at 3:00 ET
-
TheStreet.com - Nov 12 at 4:48 ET
-
DEALTALK-Stronger U.S. dollar only small factor in deals
Reuters - Oct 30 at 3:42 ET
-
Investopedia - Oct 28 at 2:21 ET
-
Aflac Q3 earnings plunge 76 percent
bizjournals.com - Oct 24 at 10:55 ET
Top members owning ACL
-
-15.13%3m:
-15.13%YTD:
-
-46.14%3m:
-45.34%YTD:
-
-21.81%3m:
-21.81%YTD: